The document discusses the legal framework for compensation and liability for drug-related injuries in clinical trials in India, including the Drugs and Cosmetics Act of 1940 and Rules of 1945 which provide for compensation in cases of death or injury resulting from clinical trials. It outlines the categories of compensation, procedures for claiming compensation, and timelines that sponsors and investigators must follow in reporting serious adverse events and making compensation payments.
Original Description:
Original Title
PPTs on COMPENSATION FOR DRUG-RELATED INJURIES [Week 14]
The document discusses the legal framework for compensation and liability for drug-related injuries in clinical trials in India, including the Drugs and Cosmetics Act of 1940 and Rules of 1945 which provide for compensation in cases of death or injury resulting from clinical trials. It outlines the categories of compensation, procedures for claiming compensation, and timelines that sponsors and investigators must follow in reporting serious adverse events and making compensation payments.
The document discusses the legal framework for compensation and liability for drug-related injuries in clinical trials in India, including the Drugs and Cosmetics Act of 1940 and Rules of 1945 which provide for compensation in cases of death or injury resulting from clinical trials. It outlines the categories of compensation, procedures for claiming compensation, and timelines that sponsors and investigators must follow in reporting serious adverse events and making compensation payments.
JGLS, SPRING 2023 INDIA DPRI Elective LEGAL FRAMEWORK IN INDIA I. DRUGS & COSMETICS ACT, 1940 II. DAC RULES, SCHEDULE Y, APPENDIX XII Read III. Formulae to Determine the Quantum of Compensation in the Cases of Clinical Trial related Serious Adverse Events of Deaths occurring during Clinical trials (CDSCO, 2013) Read IV. Formulae to Determine the Quantum of Compensation in the Cases of Clinical Trial related Serious Adverse Events of Injury Other than deaths occurring during Clinical trials (CDSCO, 2014) Read V. OTHER REMEDIES CATEGORIES OF COMPENSATION I. DEATH-RELATED CLAIMS II. PERMANENT INJURIES III. TEMPORARY INJURIES DAC RULES, 1945: RULE 122 DAB [2013] DAC RULES, 1945, RULE 122 DAB DAC RULES, 1945,RULE 122 DAB DAC RULES, 1945, RULE 122 DAB FAILURE TO COMPENSATE DAC RULES, 1945: RULE 122 DAB APPENDIX XII, SCHEDULE Y, DAC RULES, 1945 INC. BY GSR 30-01-2013 •INJURY [RULES 1-2] •DEATH [RULE 3] •FINANCIAL COMPENSATION [RULE 4] •SPONSOR [RULE 5] •PROCEDURE [RULE 6] COMPENSATION FOR DEATH OR INJURY I. Where an injury occurs during a clinical trial but later it is established that the injury is not related to the clinical trial, then in such cases free medical management shall be provided to the subject till such time it is established that there is no causal connection between the injury and the clinical trial [RULE 122DAB(1)] II. Where an injury to a trial subject is proved related to the clinical trial, then such subject shall be entitled to financial compensation over and above any expenses incurred on medical management of the subject. [RULE 122DAB(2)] COMPENSATION FOR DEATH OR INJURY III. Where there is no permanent injury, the quantum of compensation shall be equated with a non-permanent injury and the subject is to be compensated for loss of wages.[RULE 122DAB(1)] IV. In case of death of the subject, the nominee(s) shall be entitled to financial compensation over and above any expenses incurred on medical management of such subject. [APPENDIX XII, SCH. Y, DAC RULES] PROCEDURE FOR FINANCIAL COMPENSATION ITEM 6, APPENDIX XII, SCHEDULE Y, DAC RULES, 1945 A. COMPENSATION FOR SAEs CAUSING DEATH • Reporting by Investigator/Company: 24 hours • Submission of report by EC: 14 days • Final Report to Licensing Authority: 30 days • Quantum of compensation: 150 days B. COMPENSATION FOR SAEs CAUSED OTHER THAN DEATH • Quantum of compensation: 150 days (Licensing Authority) • Payment of compensation: 30 days (Sponsor) APPENDIX XII, SCHEDULE Y, DAC RULES, 1945 PROCEDURES 1. Investigator to report SAE within 24 hours to Licensing Authority. 2. Independent Expert Committee to be constituted in to examine and recommend to LA about cause and compensation. 3. Sponsor and investigator to send complete report of SAE to Ethics Committee within 14 days of event. 4. EC to forward its report to LA after due analysis within 30 days of event. APPENDIX XII, SCHEDULE Y, DAC RULES, 1945 PROCEDURES 5. LA to forward such report to Expert Committee which shall examine and make recommendations about the SAE within 105 days of the events. 6. In case of death, the Expert Comm can also recommend quantum of compensation. 7. The LA will finally decide to accept or modify the recommendations of the Expert Comm and dispose the matter within 150 days of the AE.
Doris Coal Company Old Republic Insurance Company v. Director, Office of Workers' Compensation Programs, United States Department of Labor Noah Stiltner, 938 F.2d 492, 4th Cir. (1991)